Brian P. Concannon's most recent trade in Conmed Corp. was a trade of 8,061 Options To Purchase Common Stock done . Disclosure was reported to the exchange on June 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 8,061 | 8,061 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 668 | 668 | - | - | RSUs (Restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 479 | 0 | - | - | RSUs (Restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 479 | 10,116 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 5,503 | 5,503 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 479 | 479 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 302 | 9,637 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 302 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 129.01 per share. | 07 Jun 2023 | 812 | 9,335 (0%) | 0% | 129.0 | 104,756 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 2,826 | 2,826 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 335 | 10,147 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 335 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 302 | 302 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 125.00 per share. | 01 May 2023 | 2,072 | 9,812 (0%) | 0% | 125 | 259,000 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 3,453 | 3,453 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 11,884 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 812 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 335 | 335 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 136.96 per share. | 02 Feb 2022 | 4,200 | 9,200 (0%) | 0% | 137.0 | 575,232 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 2,549 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.03 per share. | 02 Feb 2022 | 2,549 | 11,549 (0%) | 0% | 69.0 | 175,957 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 135.08 per share. | 02 Feb 2022 | 2,549 | 9,000 (0%) | 0% | 135.1 | 344,319 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.94 per share. | 02 Feb 2022 | 2,165 | 11,165 (0%) | 0% | 79.9 | 173,070 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 2,165 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 135.08 per share. | 02 Feb 2022 | 2,165 | 9,000 (0%) | 0% | 135.1 | 292,448 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 135.09 per share. | 02 Feb 2022 | 2,027 | 13,400 (0%) | 0% | 135.1 | 273,827 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 1,843 | 0 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 135.06 per share. | 02 Feb 2022 | 1,843 | 9,000 (0%) | 0% | 135.1 | 248,916 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.94 per share. | 02 Feb 2022 | 1,843 | 10,843 (0%) | 0% | 73.9 | 136,271 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 55.70 per share. | 02 Feb 2022 | 1,000 | 11,473 (0%) | 0% | 55.7 | 55,700 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.64 per share. | 02 Feb 2022 | 1,000 | 10,759 (0%) | 0% | 39.6 | 39,640 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 33.43 per share. | 02 Feb 2022 | 1,000 | 10,000 (0%) | 0% | 33.4 | 33,430 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 1,000 | 0 | - | - | Sars (Stock Appreciation Rights) | |
| Conmed Corp. | Brian P. Concannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.03 per share. | 02 Feb 2022 | 401 | 11,072 (0%) | 0% | 139.0 | 55,751 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.03 per share. | 02 Feb 2022 | 286 | 10,473 (0%) | 0% | 139.0 | 39,763 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.03 per share. | 02 Feb 2022 | 241 | 9,759 (0%) | 0% | 139.0 | 33,506 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 137.91 per share. | 02 Feb 2022 | 200 | 9,000 (0%) | 0% | 137.9 | 27,582 | Common Stock |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 15,427 (0%) | 0% | 0 | Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,521 | 0 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 865 | 865 | - | - | Options To Purchase Common Stock | |
| Conmed Corp. | Brian P. Concannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 812 | 812 | - | - | Rsus (restricted Stock Units) | |
| Conmed Corp. | Brian P. Concannon | Director | Sale of securities on an exchange or to another person at price $ 89.31 per share. | 10 Sep 2020 | 3,036 | 13,906 (0%) | 0% | 89.3 | 271,145 | Common Stock |